Janux Therapeutics shares last traded at $14.5110, with a volume of 226,221 shares traded. Wall Street Zen raised shares of Janux Therapeutics from a “sell” rating to a “hold” rating in a report on Saturday, November 8th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Janux Therapeutics in a research note on Thursday, January 22nd. Get Janux Therapeutics alerts:Read Our Latest Analysis on Janux TherapeuticsJanux Therapeutics Trading Down 5.3%The firm’s 50-day simple moving average is $17.40 and its two-hundred day simple moving average is $22.51. Featured ArticlesReceive News & Ratings for Janux Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Janux Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.